Alpha Centric Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$177.01 - $223.45 $1.81 Million - $2.29 Million	-10,250 Closed	0 $0
Q3 2021 Mar 09, 2022	BUY	$181.39 - $202.99 $544,170 - $608,970	3,000 Added 41.38%	10,250 $1.86 Million
Q2 2021 Mar 09, 2022	BUY	$187.49 - $221.1 $609,342 - $718,575	3,250 Added 81.25%	7,250 $1.46 Million
Q1 2021 Mar 09, 2022	BUY	$207.02 - $241.31 $610,709 - $711,864	2,950 Added 280.95%	4,000 $860,000
Q4 2020 Mar 11, 2022	BUY	$207.01 - $276.09 $215,290 - $287,133	1,040 Added 10400.0%	1,050 $248,000
Q2 2020 Mar 11, 2022	BUY	$225.48 - $295.8 $2,254 - $2,958	10 New	10 $3,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.